Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation C Chavey, B Mari, MN Monthouel, S Bonnafous, P Anglard, ... Journal of Biological Chemistry 278 (14), 11888-11896, 2003 | 516 | 2003 |
Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications P Basset, A Okada, MP Chenard, R Kannan, I Stoll, P Anglard, JP Bellocq, ... Matrix Biology 15 (8-9), 535-541, 1997 | 288 | 1997 |
Somatic Allelic Deletion of nm23 in Human Cancer A Leone, OW McBride, A Weston, MG Wang, P Anglard, CS Cropp, ... Cancer research 51 (9), 2490-2493, 1991 | 236 | 1991 |
Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain S Cassel, D Carouge, C Gensburger, P Anglard, C Burgun, JB Dietrich, ... Molecular pharmacology 70 (2), 487-492, 2006 | 229 | 2006 |
Molecular analysis of genetic changes in the origin and development of renal cell carcinoma P Anglard, K Tory, H Brauch, GH Weiss, F Latif, MJ Merino, MI Lerman, ... Cancer research 51 (4), 1071-1077, 1991 | 208 | 1991 |
Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma LG Gomella, ER Sargent, TP Wade, P Anglard, WM Linehan, A Kasid Cancer research 49 (24_Part_1), 6972-6975, 1989 | 195 | 1989 |
Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3 S Hosoe, H Brauch, F Latif, G Glenn, G Daniel, S Bale, P Choyke, M Gorin, ... Genomics 8 (4), 634-640, 1990 | 178 | 1990 |
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. A Ahmad, A Hanby, E Dublin, R Poulsom, P Smith, D Barnes, R Rubens, ... The American journal of pathology 152 (3), 721, 1998 | 163 | 1998 |
Chromosome 17p Deletions and p53 Mutations in Renal Cell Carcinoma RE Reiter, P Anglard, S Liu, JR Gnarra, WM Linehan Cancer research 53 (13), 3092-3097, 1993 | 136 | 1993 |
CDKL5 is a brain MeCP2 target gene regulated by DNA methylation D Carouge, L Host, D Aunis, J Zwiller, P Anglard Neurobiology of disease 38 (3), 414-424, 2010 | 130 | 2010 |
Rat liver injury following normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor R Cursio, B Mari, K Louis, P Rostagno, MC Saint-Paul, J Giudicelli, ... The FASEB Journal 16 (1), 1-24, 2002 | 121 | 2002 |
Molecular and cellular characterization of human renal cell carcinoma cell lines P Anglard, E Trahan, S Liu, F Latif, MJ Merino, MI Lerman, B Zbar, ... Cancer research 52 (2), 348-356, 1992 | 120 | 1992 |
Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase D Luo, B Mari, I Stoll, P Anglard Journal of Biological Chemistry 277 (28), 25527-25536, 2002 | 115 | 2002 |
Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co‐localization to human chromosome 1q21‐q22 C Moog‐Lutz, P Bouillet, CH Régnier, C Tomasetto, MG Mattei, ... International journal of cancer 63 (2), 297-303, 1995 | 114 | 1995 |
Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression J El Bedoui, MH Oak, P Anglard, VB Schini-Kerth Cardiovascular research 67 (2), 317-325, 2005 | 104 | 2005 |
Red Wine Polyphenolic Compounds Strongly Inhibit Pro-Matrix Metalloproteinase-2 Expression and Its Activation in Response to Thrombin via Direct Inhibition of Membrane Type 1 … MH Oak, J El Bedoui, P Anglard, VB Schini-Kerth Circulation 110 (13), 1861-1867, 2004 | 102 | 2004 |
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases M SANTAVICCA, A Noël, H ANGLIKER, I STOLL, JP SEGAIN, ... Biochemical Journal 315 (3), 953-958, 1996 | 99 | 1996 |
Structure and Promoter Characterization of the Human Stromelysin-3 Gene (∗) P Anglard, T Melot, E Guérin, G Thomas, P Basset Journal of Biological Chemistry 270 (35), 20337-20344, 1995 | 89 | 1995 |
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression P Basset, JP Bellocq, O Lefebvre, A Noël, MP Chenard, C Wolf, P Anglard, ... Critical reviews in oncology/hematology 26 (1), 43-53, 1997 | 88 | 1997 |
Molecular genetic studies of sporadic and familial renal cell carcinoma. JR Gnarra, GM Glenn, F Latif, P Anglard, MI Lerman, B Zbar, WM Linehan The Urologic Clinics of North America 20 (2), 207-216, 1993 | 86 | 1993 |